In Depth 18 Oct 2023
Going nuclear: radiopharmaceuticals see surge in funding
Emerging as a new class of drugs, radiopharmaceuticals are all the rage in cancer treatment research, at present. And now, with American biotech Nucleus RadioPharma raising $56 million to streamline its supply chains and make the drugs more accessible, it seems like the radiopharmaceutical market might be onto something big. The series A funding round, […]